Related references
Note: Only part of the references are listed.Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody
Achini Perera et al.
ARTHRITIS AND RHEUMATISM (2007)
Evidence-based guidelines for the use of immunologic tests: Anticentromere, Scl-70, and nucleolar antibodies
JD Reveille et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis
PQ Hu et al.
ARTHRITIS AND RHEUMATISM (2003)
Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis
S Sato et al.
RHEUMATOLOGY (2001)
Share Paper
